Monthly lists of letters for healthcare professionals on the safety of medicines
Copies of letters sent to healthcare professionals in October 2012, to inform of new safety information and advice:
| Date sent | Medicine | Safety information |
|---|---|---|
|
1 October 2012 |
Pegaptanib sodium (Macugen) |
Overfilled syringe causing adverse events (eg, raised intraocular pressure) – amended instructions for preparation of syringe prior to injection. |
|
10 October 2012 |
Agomelatine (Valdoxan) |
New reports of serious hepatotoxicity and the importance of monitoring liver function, including when the dose is increased. |
|
29 October 2012 |
Re-introduction of Caelyx onto the market (after its discontinuation due to production difficulties). |


